迈克生物：目前公司已将人工智能、大数据模型应用于尿液、血球、病理等项目上

Group 1 - The core viewpoint of the article highlights that Maike Bio (300463.SZ) is leveraging AI technology to innovate in the medical field, particularly through its "Smart Laboratory" platform [2] - The company has achieved full-process automation in blood collection management, sample processing, and result interpretation, creating a closed-loop system of "smart testing - smart management - smart operation" [2] - Maike Bio is currently applying AI and big data models to various projects, including urine, blood cell, and pathology tests, and is exploring broader applications of AI in the medical sector [2]